Exploring the Feasibility and Utility of the PSI in Clinical Care

• Research type

  Research Study

• Full title

  Exploring the Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings

• IRAS ID

  214070

• Contact name

  Richard Warren

• Contact email

  richard.warren@manchester.ac.uk

• Sponsor organisation

  Amgen Inc.

• Clinicaltrials.gov Identifier

  2123A, Amgen

• Duration of Study in the UK

  0 years, 1 months, 15 days

• Research summary

  The purpose of this study is to assess whether a patient-reported survey, the Psoriasis Symptom Inventory (PSI), can enhance psoriasis care management by providing the doctor with additional information from the patient’s perspective about their psoriasis symptoms. The information from this study will help to identify the usefulness of the patient-reported survey during the discussion between doctor and patient.

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  16/SC/0525

• Date of REC Opinion

  6 Oct 2016

• REC opinion

  Further Information Favourable Opinion